Analysts Issue Forecasts for XENE Q1 Earnings
Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Free Report) – William Blair issued their Q1 2026 earnings per share (EPS) estimates for shares of Xenon Pharmaceuticals in a note issued to investors on Friday, February 28th. William Blair analyst M. Minter anticipates that the biopharmaceutical company will post earnings of $0.00 per share for the quarter. William […]
